Hur, Peter
Lomax, Kathleen G.
Ionescu-Ittu, Raluca
Manceur, Ameur M.
Xie, Jipan
Cammarota, Jordan
Gautam, Raju
Sanghera, Navneet
Kim, Nina
Grom, Alexei A.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (Novartis Pharmaceuticals Corporation)
Article History
Received: 4 March 2021
Accepted: 24 May 2021
First Online: 14 September 2021
Declarations
:
: Ethics approval was obtained from the New England Independent Review Board (NEIRB, #120180302) prior to the initiation of data collection.
: Consent for publication was obtained from all authors and have reviewed the article.
: PH and NS are employees of Novartis Pharmaceuticals Corporation, USA. RG is an employee of Novartis Healthcare Pvt. Ltd., India. KGL was an employee of Novartis Pharmaceuticals Corporation, USA at the time of conduct of this study and currently is an employee of Johnson and Johnson, USA. RII, AMM, JX and JC are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Novartis for the execution of this study. NK was associated with Baylor Scott and White Medical Center, Texas and University of Texas, USA and provided services to Novartis as a postdoctoral fellow. AAG is an employee of Cincinnati Children’s Hospital Medical Center, USA and has received speaker/consulting fees from Novartis and Roche, and has been involved in research collaboration for Sobi (NovImmune).